0001415889-21-003398.txt : 20210702
0001415889-21-003398.hdr.sgml : 20210702
20210702161605
ACCESSION NUMBER: 0001415889-21-003398
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210701
FILED AS OF DATE: 20210702
DATE AS OF CHANGE: 20210702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUFFOLO ROBERT R
CENTRAL INDEX KEY: 0001187308
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39746
FILM NUMBER: 211070269
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sigilon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001821323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474005543
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BINNEY STREET
STREET 2: STE 600
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-336-7540
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
STREET 2: STE 600
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
form4-07022021_040740.xml
X0306
4
2021-07-01
0001821323
Sigilon Therapeutics, Inc.
SGTX
0001187308
RUFFOLO ROBERT R
C/O SIGILON THERAPEUTICS, INC.
100 BINNEY STREET STE 600
CAMBRIDGE
MA
02142
true
false
false
false
Common Stock
2021-07-01
4
M
0
6750
0.57
A
6750
D
Common Stock
2021-07-01
4
S
0
6750
10.36
D
0
D
Stock Option (Right to Buy)
0.57
2021-07-01
4
M
0
6750
0
D
2026-07-13
Common Stock
6750
48805
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.17 to $10.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The option vested as to 25% of the underlying shares of common stock on July 14, 2017, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the option is fully vested.
/s/ Matthew Kowalsky, Attorney-in-Fact
2021-07-02